 Medication Adherence
"Medication Adherence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Voluntary cooperation of the patient in taking drugs or medicine as prescribed. This includes timing, dosage, and frequency.
| Descriptor ID |
D055118
|
| MeSH Number(s) |
F01.100.150.750.500.600.500 F01.145.488.887.500.600.500 N05.300.150.800.500.600.500
|
| Concept/Terms |
Medication Nonadherence- Medication Nonadherence
- Nonadherence, Medication
- Medication Noncompliance
- Noncompliance, Medication
- Medication Non-Adherence
- Medication Non Adherence
- Non-Adherence, Medication
Medication Compliance- Medication Compliance
- Compliance, Medication
- Medication Non-Compliance
- Medication Non Compliance
- Non-Compliance, Medication
|
Below are MeSH descriptors whose meaning is more general than "Medication Adherence".
Below are MeSH descriptors whose meaning is more specific than "Medication Adherence".
This graph shows the total number of publications written about "Medication Adherence" by people in this website by year, and whether "Medication Adherence" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 1 | 2 | | 2009 | 7 | 3 | 10 | | 2010 | 3 | 4 | 7 | | 2011 | 8 | 8 | 16 | | 2012 | 9 | 12 | 21 | | 2013 | 7 | 6 | 13 | | 2014 | 15 | 6 | 21 | | 2015 | 16 | 9 | 25 | | 2016 | 18 | 6 | 24 | | 2017 | 23 | 7 | 30 | | 2018 | 20 | 5 | 25 | | 2019 | 14 | 13 | 27 | | 2020 | 8 | 13 | 21 | | 2021 | 3 | 20 | 23 | | 2022 | 0 | 22 | 22 | | 2023 | 3 | 18 | 21 | | 2024 | 4 | 7 | 11 | | 2025 | 11 | 6 | 17 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Medication Adherence" by people in Profiles.
-
Sun S, Nikanjam M, Mirochnick M, Powis KM, Eke AC, Stek A, Arora P, Cressey TR, Brooks KM, Best BM, Capparelli EV, Momper JD. Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure. J Clin Pharmacol. 2026 Jan; 66(1):e70134.
-
Miller SE, Dukes KA, Damato-MacPherson C, Psaros C, Scott NA, Taylor JL, Muroff J, Winter MR, Skiba LE, Lugo H, Cruz R, Ruiz-Mercado G, Crawford ND, Mayer KH, Assoumou SA. Pre-exposure prophylaxis (PrEP) and medications for opioid use disorder for persons who inject drugs: the CHORUS?+?randomized controlled trial study protocol. Addict Sci Clin Pract. 2025 Dec 25; 21(1):17.
-
Lyons ER, Vigers T, Simoni M, Lynn C, Muther E. Body Image Perceptions and Elexacaftor/Tezacaftor/Ivacaftor (ETI) Use in Adolescents and Young Adults Living With Cystic Fibrosis. Pediatr Pulmonol. 2025 Dec; 60(12):e71418.
-
Shore-Plavec R, Zucker R, Glorioso TJ, Bull S, Allen LA, Saseen JJ, Trinkley KE, Peterson P, Waughtal J, Ho PM. Engagement With Text Messaging Improves Cardiovascular Medication Adherence: Secondary Analysis of a Randomized Controlled Trial. J Med Internet Res. 2025 Nov 24; 27:e80794.
-
Sneed NM, Rifas-Shiman SL, Petimar J, Young JG, Bailey LC, Daley MF, Janicke DM, Jones WS, Prentice C, Block JP, Heerman WJ. Comparative Weight Change With Initiation and Adherence to Common Medications for Type 2 Diabetes. Obesity (Silver Spring). 2025 Nov; 33(11):2205-2213.
-
Engel N, Sykes C, Schauer AP, Kashuba ADM, Anderson PL, Bushman LR, Cottrell ML. Interlaboratory comparison of a dried blood spot assay for antiretroviral adherence: implications for clinical application. J Antimicrob Chemother. 2025 Oct 03; 80(10):2727-2731.
-
Edwards KA, Long D, Jones KF, Durr AL, Farel CE, Liebschutz JM, Bair MJ, Agil D, Napravnik S, Browne L, Johnson B, Thomas T, Burkholder G, Clay OJ, Demonte W, Orris SM, Johnson MO, Merlin J. The Skills to Manage Pain Randomized Trial: Results of Antiretroviral Therapy Adherence, HIV Primary Care Retention, and Virologic Suppression Outcomes. J Acquir Immune Defic Syndr. 2025 Oct 01; 100(2):180-185.
-
Anderson PL, Coppinger C, Cottrell ML, Marzinke MA. Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment. J Acquir Immune Defic Syndr. 2025 Oct 01; 100(2):162-169.
-
Mugwanya KK, Saina M, Mugo NR, MaWhinney S, Morrow M, Schaafsma TT, Donnell D, Glidden DV, Ngure K, Brown CE, Rechkina EA, Chohan BH, Wu L, Hill E, Koome E, Akelo N, Mbaire S, Morrison SA, Kibatha M, Njeru I, Muriithi M, Coppinger C, Bushman L, Baeten JM, Anderson PL. Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study. PLoS Med. 2025 Sep; 22(9):e1004732.
-
Narcisse DI, Whittle J, Rhodes GM, Stebbins AL, Wruck LM, Mulder H, Kripalani S, Muñoz D, Effron MB, Gupta K, Handberg EM, Girotra S, Hess R, Benziger CP, Farrehi P, VanWormer JJ, Knowlton KU, Polonsky TS, Bradley SM, Robertson HR, Hammill BG, Rothman RL, Harrington RA, Jones WS, Hernandez AF. Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trial. Contemp Clin Trials. 2025 Sep; 156:108030.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|